Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring

Journal of Proteome Research

Volumn 10, Issue 9, 2011, Pages 4005-4017

  Tang, Hsin Yao ^a   Beer, Lynn A ^a   Barnhart, Kurt T ^b   Speicher, David W ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biomarker validation; biomarker verification; label free quantitation; multiple reaction monitoring (MRM); serum biomarkers; serum proteomes

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE DERIVATIVE; STABLE ISOTOPE;

ARTICLE; CHEMICAL REACTION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FRACTIONATION; GEL; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; MOLECULAR WEIGHT; MONITORING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SEROLOGY;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; BLOOD PROTEINS; CATHEPSIN D; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOASSAY; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 80052431797     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr2002098     Document Type: Article

References (49)

1. Veenstra, T. D.; Conrads, T. P.; Hood, B. L.; Avellino, A. M.; Ellenbogen, R. G.; Morrison, R. S. Biomarkers: mining the biofluid proteome Mol. Cell. Proteomics 2005, 4 (4) 409-18 (Pubitemid 40590561)
2. Hoffman, S. A.; Joo, W. A.; Echan, L. A.; Speicher, D. W. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007, 849 (1-2) 43-52 (Pubitemid 46529317)
3. Teng, P. N.; Bateman, N. W.; Hood, B. L.; Conrads, T. P. Advances in proximal fluid proteomics for disease biomarker discovery J. Proteome Res. 2010, 9 (12) 6091-100
4. Jimenez, C. R.; Knol, J. C.; Meijer, G. A.; Fijneman, R. J. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers J. Proteomics 2010, 73 (10) 1873-95
5. Makridakis, M.; Vlahou, A. Secretome proteomics for discovery of cancer biomarkers J. Proteomics 2010, 73 (12) 2291-305
6. Goo, Y. A.; Goodlett, D. R. Advances in proteomic prostate cancer biomarker discovery J. Proteomics 2010, 73 (10) 1839-50
7. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24 (8) 971-83 (Pubitemid 44215392)
8. Anderson, L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol. 2005, 563 (Pt 1) 23-60
9. Surinova, S.; Schiess, R.; Huttenhain, R.; Cerciello, F.; Wollscheid, B.; Aebersold, R. On the development of plasma protein biomarkers J. Proteome Res. 2011, 10 (1) 5-16
10. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5 (4) 573-88
11. Domon, B.; Aebersold, R. Options and considerations when selecting a quantitative proteomics strategy Nat. Biotechnol. 2010, 28 (7) 710-21
12. Stahl-Zeng, J.; Lange, V.; Ossola, R.; Eckhardt, K.; Krek, W.; Aebersold, R.; Domon, B. High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites Mol. Cell. Proteomics 2007, 6 (10) 1809-17 (Pubitemid 350031682)
13. Barnidge, D. R.; Goodmanson, M. K.; Klee, G. G.; Muddiman, D. C. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry J. Proteome Res. 2004, 3 (3) 644-52 (Pubitemid 39207371)
14. Barr, J. R.; Maggio, V. L.; Patterson, D. G., Jr; Cooper, G. R.; Henderson, L. O.; Turner, W. E.; Smith, S. J.; Hannon, W. H.; Needham, L. L.; Sampson, E. J. Isotope dilution - mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I Clin. Chem. 1996, 42 (10) 1676-82 (Pubitemid 26354748)
15. Barnidge, D. R.; Dratz, E. A.; Martin, T.; Bonilla, L. E.; Moran, L. B.; Lindall, A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards Anal. Chem. 2003, 75 (3) 445-51 (Pubitemid 36176714)
16. Gerber, S. A.; Rush, J.; Stemman, O.; Kirschner, M. W.; Gygi, S. P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (12) 6940-5 (Pubitemid 36706372)
17. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2007, 6 (12) 2212-29
18. Hoofnagle, A. N.; Becker, J. O.; Wener, M. H.; Heinecke, J. W. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry Clin. Chem. 2008, 54 (11) 1796-804
19. Keshishian, H.; Addona, T.; Burgess, M.; Mani, D. R.; Shi, X.; Kuhn, E.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2009, 8 (10) 2339-49
20. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-41
21. Brun, V.; Dupuis, A.; Adrait, A.; Marcellin, M.; Thomas, D.; Court, M.; Vandenesch, F.; Garin, J. Isotope-labeled protein standards: toward absolute quantitative proteomics Mol. Cell. Proteomics 2007, 6 (12) 2139-49
22. Kito, K.; Ota, K.; Fujita, T.; Ito, T. A synthetic protein approach toward accurate mass spectrometric quantification of component stoichiometry of multiprotein complexes J. Proteome Res. 2007, 6 (2) 792-800 (Pubitemid 46340182)
23. Pratt, J. M.; Simpson, D. M.; Doherty, M. K.; Rivers, J.; Gaskell, S. J.; Beynon, R. J. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes Nat. Protoc. 2006, 1 (2) 1029-43
24. DeSouza, L. V.; Taylor, A. M.; Li, W.; Minkoff, M. S.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues J. Proteome Res. 2008, 7 (8) 3525-34
25. Zhao, Y.; Jia, W.; Sun, W.; Jin, W.; Guo, L.; Wei, J.; Ying, W.; Zhang, Y.; Xie, Y.; Jiang, Y.; He, F.; Qian, X. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer J. Proteome Res. 2010, 9 (6) 3319-27
26. Mirzaei, H.; McBee, J. K.; Watts, J.; Aebersold, R. Comparative evaluation of current peptide production platforms used in absolute quantification in proteomics Mol. Cell. Proteomics 2008, 7 (4) 813-23 (Pubitemid 351597489)
27. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 2002, 1 (11) 845-67
28. Sherman, J.; McKay, M. J.; Ashman, K.; Molloy, M. P. How specific is my SRM?: The issue of precursor and product ion redundancy Proteomics 2009, 9 (5) 1120-3
29. Lee, A. Y.; Paweletz, C. P.; Pollock, R. M.; Settlage, R. E.; Cruz, J. C.; Secrist, J. P.; Miller, T. A.; Stanton, M. G.; Kral, A. M.; Ozerova, N. D.; Meng, F.; Yates, N. A.; Richon, V.; Hendrickson, R. C. Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry J. Proteome Res. 2008, 7 (12) 5177-86
30. Nittis, T.; Guittat, L.; LeDuc, R. D.; Dao, B.; Duxin, J. P.; Rohrs, H.; Townsend, R. R.; Stewart, S. A. Revealing novel telomere proteins using in vivo cross-linking, tandem affinity purification, and label-free quantitative LC-FTICR-MS Mol. Cell. Proteomics 2010, 9 (6) 1144-56
31. Paweletz, C. P.; Wiener, M. C.; Bondarenko, A. Y.; Yates, N. A.; Song, Q.; Liaw, A.; Lee, A. Y.; Hunt, B. T.; Henle, E. S.; Meng, F.; Sleph, H. F.; Holahan, M.; Sankaranarayanan, S.; Simon, A. J.; Settlage, R. E.; Sachs, J. R.; Shearman, M.; Sachs, A. B.; Cook, J. J.; Hendrickson, R. C. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry J. Proteome Res. 2010, 9 (3) 1392-401
32. Nagaraj, N.; Mann, M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome J. Proteome Res. 2011, 10 (2) 637-45
33. Beer, L. A.; Tang, H. Y.; Sriswasdi, S.; Barnhart, K. T.; Speicher, D. W. Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation J. Proteome Res. 2011, 10 (3) 1126-38
34. Whiteaker, J. R.; Zhang, H.; Zhao, L.; Wang, P.; Kelly-Spratt, K. S.; Ivey, R. G.; Piening, B. D.; Feng, L. C.; Kasarda, E.; Gurley, K. E.; Eng, J. K.; Chodosh, L. A.; Kemp, C. J.; McIntosh, M. W.; Paulovich, A. G. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer J. Proteome Res. 2007, 6 (10) 3962-75 (Pubitemid 350032560)
35. Choi, S.; Kim, J.; Yea, K.; Suh, P. G.; Ryu, S. H. Targeted label-free quantitative analysis of secretory proteins from adipocytes in response to oxidative stress Anal. Biochem. 2010, 401 (2) 196-202
36. Tang, H. Y.; Beer, L. A.; Speicher, D. W. In-depth analysis of a plasma or serum proteome using a 4D protein profiling method Methods Mol. Biol. 2011, 728, 47-67
37. Han, M. J.; Wang, H.; Beer, L. A.; Tang, H. Y.; Herlyn, M.; Speicher, D. W. A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling Proteomics 2010, 10 (24) 4450-62
38. Anderson, N. L. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum Clin. Chem. 2010, 56 (2) 177-85
39. Rausch, M. E.; Beer, L.; Sammel, M. D.; Takacs, P.; Chung, K.; Shaunik, A.; Speicher, D.; Barnhart, K. T. A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy Fertil. Steril. 2011, 95 (4) 1373-8
40. Manevich, Y.; Fisher, A. B. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism Free Radical Biol. Med. 2005, 38 (11) 1422-32 (Pubitemid 40693827)
41. Lee, S. B.; Ho, J. N.; Yoon, S. H.; Kang, G. Y.; Hwang, S. G.; Um, H. D. Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt Mol. Cells 2009, 28 (6) 583-8
42. Ho, J. N.; Lee, S. B.; Lee, S. S.; Yoon, S. H.; Kang, G. Y.; Hwang, S. G.; Um, H. D. Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells Mol. Cancer Ther. 2010, 9 (4) 825-32
43. Benes, P.; Vetvicka, V.; Fusek, M. Cathepsin D - many functions of one aspartic protease Crit. Rev. Oncol. Hematol. 2008, 68 (1) 12-28
44. Zuhlsdorf, M.; Imort, M.; Hasilik, A.; von Figura, K. Molecular forms of beta-hexosaminidase and cathepsin D in serum and urine of healthy subjects and patients with elevated activity of lysosomal enzymes Biochem. J. 1983, 213 (3) 733-40 (Pubitemid 13044143)
45. Leto, G.; Tumminello, F. M.; Crescimanno, M.; Flandina, C.; Gebbia, N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications Clin. Exp. Metastasis 2004, 21 (2) 91-106 (Pubitemid 38988083)
46. Brouillet, J. P.; Dufour, F.; Lemamy, G.; Garcia, M.; Schlup, N.; Grenier, J.; Mani, J. C.; Rochefort, H. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay Cancer 1997, 79 (11) 2132-6 (Pubitemid 27227377)
47. Mallick, P.; Schirle, M.; Chen, S. S.; Flory, M. R.; Lee, H.; Martin, D.; Ranish, J.; Raught, B.; Schmitt, R.; Werner, T.; Kuster, B.; Aebersold, R. Computational prediction of proteotypic peptides for quantitative proteomics Nat. Biotechnol. 2007, 25 (1) 125-31 (Pubitemid 46098780)
48. Merseburger, A. S.; Hennenlotter, J.; Stenzl, A.; Beger, G.; Rinnab, L.; Kuczyk, M. A.; Kuefer, R. Cathepsin D serum levels are not a valid serum marker in renal cell carcinoma Urol. Int. 2007, 79 (1) 41-3 (Pubitemid 47051817)
49. Fukuda, M. E.; Iwadate, Y.; Machida, T.; Hiwasa, T.; Nimura, Y.; Nagai, Y.; Takiguchi, M.; Tanzawa, H.; Yamaura, A.; Seki, N. Cathepsin D is a potential serum marker for poor prognosis in glioma patients Cancer Res. 2005, 65 (12) 5190-4 (Pubitemid 40827328)